flufenamic acid has been researched along with 4-amylcinnamoylanthranilic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Bartlett, SJ; Bauche, A; Fliegert, R; Guse, AH; Harneit, A; Kirchberger, T; Moreau, C; Potter, BV; Swarbrick, JM; Yorgan, T | 1 |
Boa, AN; Chandrabalan, A; McPhillie, MJ; Morice, AH; Sadofsky, LR | 1 |
Jin, H; Jin, Z; Lin, H; Liu, Z; Xu, Q; Yang, W; Yu, P; Zhang, H; Zhang, L; Zhang, Y; Zhao, S | 1 |
Frenzel, H; Harteneck, C; Kraft, R | 1 |
Inada, H; Togashi, K; Tominaga, M | 1 |
Chung, KK; Freestone, PS; Guatteo, E; Lipski, J; Mercuri, NB; Nicholson, LF | 1 |
1 review(s) available for flufenamic acid and 4-amylcinnamoylanthranilic acid
Article | Year |
---|---|
N-(p-amylcinnamoyl)anthranilic acid (ACA): a phospholipase A(2) inhibitor and TRP channel blocker.
Topics: Animals; Arachidonic Acid; Calcium Signaling; Cinnamates; Diglycerides; Drug Design; Enzyme Inhibitors; Flufenamic Acid; Humans; Ion Channel Gating; Molecular Structure; ortho-Aminobenzoates; Phospholipases A; TRPC Cation Channels; TRPM Cation Channels | 2007 |
5 other study(ies) available for flufenamic acid and 4-amylcinnamoylanthranilic acid
Article | Year |
---|---|
Structure-activity relationship of adenosine 5'-diphosphoribose at the transient receptor potential melastatin 2 (TRPM2) channel: rational design of antagonists.
Topics: Adenosine Diphosphate Ribose; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; TRPM Cation Channels | 2013 |
N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
Topics: Animals; Calcium Signaling; Cinnamates; Guinea Pigs; HEK293 Cells; Humans; Male; Molecular Docking Simulation; ortho-Aminobenzoates; Structure-Activity Relationship; TRPA1 Cation Channel | 2019 |
The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo.
Topics: Animals; Cell Line, Tumor; Cinnamates; Glucose; HEK293 Cells; Humans; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Molecular Structure; Neuroprotective Agents; ortho-Aminobenzoates; Oxygen; Reperfusion Injury; Structure-Activity Relationship; TRPM Cation Channels | 2021 |
Inhibition of the transient receptor potential cation channel TRPM2 by 2-aminoethoxydiphenyl borate (2-APB).
Topics: Adenosine Diphosphate Ribose; Animals; Antifungal Agents; Boron Compounds; Cell Line; Cinnamates; Cyclic ADP-Ribose; Dose-Response Relationship, Drug; Flufenamic Acid; Hot Temperature; Humans; In Vitro Techniques; Inhibitory Concentration 50; Insulin; Insulin Secretion; Islets of Langerhans; Male; ortho-Aminobenzoates; Patch-Clamp Techniques; Rats; Rats, Wistar; Transfection; TRPM Cation Channels | 2008 |
Acute action of rotenone on nigral dopaminergic neurons--involvement of reactive oxygen species and disruption of Ca2+ homeostasis.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Animals, Newborn; Antioxidants; Biophysical Phenomena; Biophysics; Calcium; Chromans; Cinnamates; Clusterin; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Female; Flufenamic Acid; Homeostasis; In Vitro Techniques; Insecticides; Male; Membrane Potential, Mitochondrial; Membrane Potentials; Neurons; ortho-Aminobenzoates; Patch-Clamp Techniques; Rats; Rats, Wistar; Reactive Oxygen Species; Rotenone; Sodium; Substantia Nigra; Tolbutamide | 2009 |